Orally Administered Natural Lipid Nanoparticle-Loaded 6-Shogaol Shapes the Anti-Inflammatory Microbiota and Metabolome

Gut Microbiota Variation With Short-Term Intake of Ginger Juice on Human Health

(2021) Xiaolong Wang et al.   Frontiers in Microbiology

Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes

(2021) Iris Bischoff-Kont et al.   Pharmaceuticals

Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis

(2020) Chunhua Yang et al.   JOURNAL OF CONTROLLED RELEASE

METLIN MS2 molecular standards database: a broad chemical and biological resource

(2020) Jingchuan Xue et al.   NATURE METHODS

Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations

(2020) Andrea Quagliariello et al.   Microorganisms

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?

(2019) Loris Lopetuso et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Intestinal microbiome as a novel therapeutic target for local and systemic inflammation

(2019) Kazuhiko Uchiyama et al.   PHARMACOLOGY & THERAPEUTICS

Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease

(2019) Robert P Hirten et al.   INFLAMMATORY BOWEL DISEASES

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome

(2019) Israr Khan et al.   Pathogens

6-Shogaol Inhibits Advanced Glycation End-Products-Induced IL-6 and ICAM-1 Expression by Regulating Oxidative Responses in Human Gingival Fibroblasts

(2019) Nonaka et al.   MOLECULES

The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery

(2019) Jeffrey A. van Santen et al.   ACS Central Science

Improved succinate production from galactose‐rich feedstocks by engineered Escherichia coli under anaerobic conditions

(2019) Fayin Zhu et al.   BIOTECHNOLOGY AND BIOENGINEERING

The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2019) Sudabeh Alatab et al.   Lancet Gastroenterology & Hepatology

Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections

(2018) Sehrish Jamot et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease

(2018) Alka Goyal et al.   INFLAMMATORY BOWEL DISEASES

Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines

(2018) Chunhua Yang et al.   Journal of Materials Chemistry B

Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota

(2018) Yun Teng et al.   Cell Host & Microbe

Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection in Pediatric Inflammatory Bowel Disease

(2018) Stanley Cho et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis

(2017) Mingzhen Zhang et al.   Journal of Crohns & Colitis

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer

(2016) Mingzhen Zhang et al.   BIOMATERIALS

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease

(2016) Alice Yuxin Wang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Elicitation of secondary metabolism in actinomycetes

(2015) Usama Ramadan Abdelmohsen et al.   BIOTECHNOLOGY ADVANCES

MicroRNAs as Therapeutic Targets in Colitis and Colitis-Associated Cancer: Tiny Players With a Giant Impact

(2015) Ajay Goel   GASTROENTEROLOGY

The gut microbiota and host health: a new clinical frontier

(2015) Julian R Marchesi et al.   GUT

Small molecules from the human microbiota

(2015) M. S. Donia et al.   SCIENCE

Anti-Adhesion Molecules: is Gut Specificity the Key for a Good Safety Profile?

(2012) Patrick B Allen   Current Drug Delivery

Ulcerative Colitis

(2011) Silvio Danese et al.   NEW ENGLAND JOURNAL OF MEDICINE

The gut microbiome as therapeutic target

(2011) Patrice D. Cani et al.   PHARMACOLOGY & THERAPEUTICS

Differential Selectivity of the Escherichia coli Cell Membrane Shifts the Equilibrium for the Enzyme-Catalyzed Isomerization of Galactose to Tagatose

(2008) J.-H. Kim et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

6-Shogaol induces apoptosis in human colorectal carcinoma cellsviaROS production, caspase activation, and GADD 153 expression

(2008) Min-Hsiung Pan et al.   MOLECULAR NUTRITION & FOOD RESEARCH